Recruiting
Metastatic renal cell carcinoma
RecruitingRegistered drugNo placebo
Study Comparing Gallium (68Ga) Gozetotide and Zirconium (89Zr) Girentuximab PET Scans for Detecting Tumors in Patients with Metastatic Renal Cell Carcinoma
Registered drugNo placebo
- Disease:Metastatic renal cell carcinoma
- Substances:GozetotideGallium (68Ga) Gozetotide+1
Countries:
The Netherlands
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Gozetotide
- Sponsor:Stichting Radboud universitair medisch centrum







